Dose-response relationships for late radiation effects in the head and neck: regarding the analysis of the RTOG 8313 trial, Fu et al. IJROBP 32:577-588; 1995.

[1]  A. Ruifrok,et al.  Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  H. Withers,et al.  Dose-response for subclinical disease--in response to Dr. Ben-Josef. , 1995, International journal of radiation oncology, biology, physics.

[3]  H. Withers,et al.  Interfraction interval and dose-response in RTOG trials--regarding Fu et al., IJROBP 32:577-588; 1995. , 1995, International Journal of Radiation Oncology, Biology, Physics.

[4]  P. Rubin,et al.  Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. , 1995, International journal of radiation oncology, biology, physics.

[5]  A. Becker.  [Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma]. , 1995, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[6]  S. Bentzen.  Radiobiological considerations in the design of clinical trials. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  H. Thames,et al.  Is the experience with CHART compatible with experimental data? A new model of repair kinetics and computer simulations. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  P. Rubin,et al.  ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313. , 1991, International journal of radiation oncology, biology, physics.

[9]  I. Turesson.  Characteristics of dose-response relationships for late radiation effects: an analysis of skin telangiectasia and of head and neck morbidity. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  H D Thames,et al.  Time-dose factors in radiotherapy: a review of the human data. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  T. Pajak,et al.  Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG). , 1987, International journal of radiation oncology, biology, physics.

[12]  H D Thames,et al.  An 'incomplete-repair' model for survival after fractionated and continuous irradiations. , 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine.